Inflammatory Adverse Events are Associated with Disease-Free Survival after Vaccine Therapy among Patients with Melanoma

Por Hu, Yinin, Smolkin, Mark E., White, Emily J., Petroni, Gina R., Neese, Patrice Y., Slingluff, Craig L.
Publicado em 2014

Helper T-Cell Responses and Clinical Activity of a Melanoma Vaccine With Multiple Peptides From MAGE and Melanocytic Differentiation Antigens

Por Slingluff, Craig L., Petroni, Gina R., Olson, Walter, Czarkowski, Andrea, Grosh, William W., Smolkin, Mark, Chianese-Bullock, Kimberly A., Neese, Patrice Y., Deacon, Donna H., Nail, Carmel, Merrill, Priscilla, Fink, Robyn, Patterson, James W., Rehm, Patrice K.
Publicado em 2008

Evaluation of the Sentinel Immunized Node for Immune Monitoring of Cancer Vaccines

Por Slingluff, Craig L., Yamshchikov, Galina V., Hogan, Kevin T., Hibbitts, Sarah C., Petroni, Gina R., Bissonette, Eric A., Patterson, James W., Neese, Patrice Y., Grosh, William W., Chianese-Bullock, Kimberly A., Czarkowski, Andrea, Rehm, Patrice K., Parekh, Jayashree
Publicado em 2008

IMMUNOGENICITY FOR CD8+ AND CD4+ T CELLS OF TWO FORMULATIONS OF AN INCOMPLETE FREUND’S ADJUVANT FOR MULTIPEPTIDE MELANOMA VACCINES

Por Slingluff, Craig L., Petroni, Gina R., Smolkin, Mark E., Chianese-Bullock, Kimberly A., Smith, Kelly, Murphy, Cheryl, Galeassi, Nadedja, Neese, Patrice Y., Grosh, William W., Nail, Carmel J., Ross, Merrick, Haas, Naomi, Boisvert, Marc E, Kirkwood, John M.
Publicado em 2010